XT
BLTE

XTX Topco’s Belite Bio BLTE Stock Holding History

XTX Topco’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$667K Sell
4,333
-10,725
-71% -$1.64M 0.01% 2162
2026
Q1 		$2.4M Buy
+15,058
New +$2.53M 0.04% 699
2025
Q1 		– Sell
-7,062
Closed -$446K – 2437
2024
Q4 		$446K Buy
7,062
+1,668
+31% +$110K 0.04% 868
2024
Q3 		$253K Buy
+5,394
New +$261K 0.02% 1305

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco's BLTE Position: Q2 2026 in Review

XTX Topco reduced its Belite Bio (BLTE) stake by 71% in Q2 2026, selling an estimated $1.64M and leaving 4,333 shares worth $667K. The position accounts for 0.01% of the portfolio, ranked #2162.

XTX Topco first reported a position in BLTE in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.4M in Q1 2026. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • XTX Topco held 4,333 shares of Belite Bio worth $667K as of Q2 2026.
  • XTX Topco sold 10,725 Belite Bio shares in Q2 2026, an estimated $1.64M.
  • Belite Bio made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2162 holding.
  • XTX Topco first reported a position in Belite Bio in Q3 2024 and has held it in 4 quarters since.
  • XTX Topco's Belite Bio position peaked at $2.4M in Q1 2026.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.